ARTICLE | Financial News
InterMune raises $76 million
August 17, 2000 7:00 AM UTC
ITMN, which markets its Actimmune interferon gamma-1b to treat chronic granulomatous disease and severe malignant osteopetrosis, raised $76 million through the private placement of 2 million shares at...